Gilad Oren
Aprea Therapeutics, Inc. · President/CEO
Gilad Oren is listed in public filings as director, officer: President/CEO. This Gilad Oren insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aprea Therapeutics, Inc. (APRE). Investors use Gilad Oren's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --393.9k shares | Grant / ExerciseMar 12, 2026 | Disclosure amount unavailable20.2k shares | -- | -- | |
| $62k80.7k shares | Grant / ExerciseMar 12, 2026 | $61.7K80.7k shares | $0.765 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $333k373.7k shares | BuyJan 30, 2026 | $25.0K28.1k shares | $0.89 | -- | |
| $21k28.1k shares | BuyJan 30, 2026 | $21.5K28.1k shares | $0.765 | -- | |
| $221.5k shares | BuyDec 10, 2025 | $221.5k shares | $0.0001 | -- | |
| $22k21.5k shares | BuyDec 10, 2025 | $22.3K21.5k shares | $1.04 | -- | |
| $622k345.6k shares | BuyApr 3, 2025 | $4.5K2.5k shares | $1.80 | -- | |
| $642k343.1k shares | BuyApr 3, 2025 | $5.6K3k shares | $1.87 | -- | |
| --340.1k shares | Grant / ExerciseMar 27, 2025 | Disclosure amount unavailable6.7k shares | -- | -- | |
| $59k26.9k shares | Grant / ExerciseMar 27, 2025 | $59.2K26.9k shares | $2.20 | -- | |
| $1.3M333.4k shares | BuyOct 23, 2024 | $2.0K500 shares | $3.92 | -- | |
| $965k332.9k shares | BuyOct 15, 2024 | $725250 shares | $2.90 | -- | |
| $862k332.6k shares | BuyOct 14, 2024 | $2.6K1k shares | $2.59 | -- | |
| $842k331.6k shares | BuyOct 10, 2024 | $381150 shares | $2.54 | -- |